Further validation through multivariate Cox regression analyses consistently demonstrated that elevated CENPF protein expression remained a strong and independent prognostic factor for both DFS and OS among CRC patients within the external validation cohort II (Table 2). This evidence concerns the gene CENPF and colorectal carcinoma.